$OM insider trading
Over the last 12 months, Outset Medical insiders reported no purchases and 17 sales totaling $341K across SEC Form 4 filings.
- Bought · 12m
- — 0 events
- Sold · 12m
- $341K 17 events
- Events · 12m
- 17 Form 4 filings, grouped
- Insiders · 12m
- 5 distinct reporters
- 10b5-1 share
- 0% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Trigg LeslieChair and CEO · O·D | ▼ Sale | 3,437 | $4.39 | $15K | -1.7% | — |
| Aug 17, 2026 | Brottem John L.General Counsel · O | ▼ Sale | 2,632 | $4.39 | $12K | -2.9% | — |
| Aug 17, 2026 | Gaeta ReneeChief Financial Officer · O | ▼ Sale | 4,543 | $4.39 | $20K | -2.5% | — |
| Jun 3, 2026 | Gaeta ReneeChief Financial Officer · O | ▼ Sale | 17,672 | $4.94 | $87K | -13.4% | — |
| Feb 17, 2026 | Nash MarcEVP Operations R&D & Service · O | ▼ Sale | 1,817 | $3.35 | $6K | -4.3% | — |
| Feb 17, 2026 | Brottem John L.General Counsel · O | ▼ Sale | 2,842 | $3.35 | $10K | -7.9% | — |
| Feb 17, 2026 | Trigg LeslieChair and CEO · O·D | ▼ Sale | 3,361 | $3.35 | $11K | -3.2% | — |
| Jan 21, 2026 | Nash MarcEVP Operations R&D & Service · O | ▼ Sale | 6,355 | $5.1 | $32K | -13.2% | 2 tranches |
| Jan 21, 2026 | Brottem John L.General Counsel · O | ▼ Sale | 10,494 | $5.11 | $54K | -22.7% | 2 tranches |
| Jan 21, 2026 | Trigg LeslieChair and CEO · O·D | ▼ Sale | 13,914 | $5.11 | $71K | -11.6% | 2 tranches |
| Jan 7, 2026 | Nash MarcEVP Operations R&D & Service · O | ▼ Sale | 108 | $4.27 | $461 | -0.2% | — |
| Jan 7, 2026 | Brottem John L.General Counsel · O | ▼ Sale | 224 | $4.27 | $956 | -0.5% | — |
| Jan 7, 2026 | Trigg LeslieChair and CEO · O·D | ▼ Sale | 1,795 | $4.27 | $8K | -1.5% | — |
| Dec 1, 2025 | Drexler KarenD | ▼ Sale | 1,548 | $4.37 | $7K | -12.7% | — |
| Nov 17, 2025 | Trigg LeslieChair and CEO · O·D | ▼ Sale | 916 | $4.6 | $4K | -0.7% | — |
| Nov 17, 2025 | Nash MarcEVP Operations R&D & Service · O | ▼ Sale | 247 | $4.6 | $1K | -0.5% | — |
| Nov 17, 2025 | Brottem John L.General Counsel · O | ▼ Sale | 388 | $4.6 | $2K | -0.8% | — |
| Aug 15, 2025 | Trigg LeslieChair and CEO · O·D | ▼ Sale | 904 | $12.88 | $12K | -0.7% | — |
| Aug 15, 2025 | Nash MarcSVP Operations and R&D · O | ▼ Sale | 243 | $12.88 | $3K | -0.6% | — |
| Aug 15, 2025 | Brottem John L.General Counsel · O | ▼ Sale | 383 | $12.88 | $5K | -0.8% | — |
Every $OM filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Outset Medical filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $OM feed.